Search clinical trials for: Induction without Brentuximab Vedotin
Total 263 results
-
Beijing VDJBio Co., LTD.RecruitingIdiopathic Multicentric Castleman's DiseaseChina
-
The First Affiliated Hospital with Nanjing Medical...Completed
-
Hoffmann-La RocheCompletedB-cell Non-Hodgkin LymphomaUnited States, Spain, Korea, Republic of, France, Austria, Poland
-
University of WashingtonNational Cancer Institute (NCI)WithdrawnAnaplastic Large Cell Lymphoma, ALK-Positive | CD30-Positive Neoplastic Cells Present | Systemic Anaplastic Large Cell LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRelapsed Classic Hodgkin LymphomaUnited States
-
John ReneauActive, not recruitingRecurrent T-Cell Non-Hodgkin Lymphoma | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma | Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma | Primary Cutaneous Anaplastic Large Cell Lymphoma | Refractory Primary Cutaneous T-Cell Non-Hodgkin... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Classic Hodgkin LymphomaUnited States
-
Grupo Español de Linfomas y Transplante Autólogo...Millennium Pharmaceuticals, Inc.CompletedCLASSICAL HODGKIN LYMPHOMASpain
-
Insel Gruppe AG, University Hospital BernRecruitingAortic Valve Replacement in Patients With Moderate Aortic Stenosis Combined With Mitral RegurgitationSwitzerland
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin LymphomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedEverolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin LymphomaRecurrent Hodgkin Lymphoma | Refractory Hodgkin LymphomaUnited States
-
University of LouisvilleWithdrawn
-
Joseph TuscanoNational Cancer Institute (NCI); Seagen Inc.RecruitingBrentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular LymphomaRecurrent Follicular Lymphoma | Refractory Follicular LymphomaUnited States
-
University of CologneCompletedHodgkin LymphomaGermany
-
University of WashingtonRecruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin LymphomaUnited States
-
King Abdullah International Medical Research CenterUnknownHodgkin Disease | Hodgkin Lymphoma | Classical Hodgkin Lymphoma | Hodgkin Lymphoma (Category)Saudi Arabia
-
Shanghai Junshi Bioscience Co., Ltd.CompletedNasopharyngeal Carcinoma | Head and Neck Squamous Cell CarcinomChina
-
National Cancer Institute (NCI)CompletedRecurrent Adult Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Hodgkin Lymphoma | Refractory Childhood Hodgkin Lymphoma | Recurrent Childhood Hodgkin LymphomaUnited States, Canada
-
Mansoura UniversityUnknown
-
Medical College of WisconsinChildren's Hospital and Health System Foundation, WisconsinCompletedPost Operative PainUnited States
-
Weill Medical College of Cornell UniversityGenentech, Inc.RecruitingChronic Lymphocytic Leukemia | Richter SyndromeUnited States
-
ClinAmygateFayoum University Hospital; Misr University for Science and Technology; Al Safwa...CompletedLaparoscopic Surgery | Surgical Wound | Surgical Site InfectionEgypt
-
University of CologneActive, not recruiting
-
Trans Tasman Radiation Oncology GroupThe Royal Australian and New Zealand College of RadiologistsCompletedGastric CancerAustralia, New Zealand
-
GEM Hospital & Research CenterCompleted
-
Fayoum University HospitalRecruiting
-
Emory UniversityNational Cancer Institute (NCI)RecruitingRecurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Hodgkin Lymphoma | Adult Lymphocyte Depletion Hodgkin Lymphoma | Adult Lymphocyte Predominant Hodgkin Lymphoma | Adult Mixed Cellularity Hodgkin Lymphoma | Adult Nodular Sclerosis Hodgkin LymphomaUnited States
-
USWM, LLC (dba US WorldMeds)National Institute on Drug Abuse (NIDA)RecruitingOpioid Withdrawal (Disorder)United States
-
I.M. Sechenov First Moscow State Medical UniversityNanoPass Technologies LtdCompleted
-
National Cancer Institute (NCI)TerminatedAnaplastic Large Cell LymphomaUnited States
-
New York Medical CollegeUniversity of Alabama at BirminghamRecruitingPeripheral T Cell Lymphoma | NK-Cell Lymphoma | NK-Cell LeukemiaUnited States
-
University Hospital Fattouma BourguibaCompleted
-
MemorialCare Health SystemMemorial Medical Center FoundationCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Hodgkin Lymphoma | Refractory Hodgkin LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of Michigan; University of North Carolina, Chapel HillCompletedBreast CancerUnited States
-
HIV Prevention Trials NetworkNational Institute on Drug Abuse (NIDA); National Institute of Allergy and...Enrolling by invitationHIV Infections | Opioid Use | Drug Use | Opioid-use DisorderUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedKidney Cancer | Renal CancerUnited States
-
St. Jude Children's Research HospitalSeagen Inc.; Teva Pharmaceuticals USARecruiting
-
Universitätsklinikum Hamburg-EppendorfDeutsche KinderkrebsstiftungActive, not recruitingBrain TumorsGermany, Denmark, United Kingdom, Belgium, Poland, Ireland, Austria, Italy, Czechia, France, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland
-
Henrik GregersenNordic Myeloma Study GroupUnknownMultiple MyelomaFinland, Denmark, Sweden, Norway, Lithuania
-
Evergreen Therapeutics, Inc.Not yet recruitingAdvanced Endometrial Cancer
-
National Cancer Institute (NCI)TerminatedAnaplastic Large Cell Lymphoma | Recurrent Childhood Anaplastic Large Cell LymphomaUnited States
-
Qianfoshan HospitalRecruiting
-
University of Alabama at BirminghamWithdrawnBack PainUnited States
-
University of BathCompletedObesity | Type 2 DiabetesUnited Kingdom
-
University of WashingtonNational Cancer Institute (NCI); Seagen Inc.Active, not recruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin LymphomaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingClassic Hodgkin Lymphoma | Ann Arbor Stage IB Hodgkin Lymphoma | Ann Arbor Stage II Hodgkin Lymphoma | Ann Arbor Stage IIA Hodgkin Lymphoma | Ann Arbor Stage IIB Hodgkin Lymphoma | Ann Arbor Stage I Hodgkin Lymphoma | Ann Arbor Stage IA Hodgkin LymphomaUnited States